Catalyst Pharmaceuticals (CPRX)
(Delayed Data from NSDQ)
$14.72 USD
-0.30 (-2.00%)
Updated May 3, 2024 04:00 PM ET
After-Market: $14.72 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: AMC |
3/2024 | $0.34 | 1.19% |
Earnings Summary
For their last quarter, Catalyst Pharmaceuticals (CPRX) reported earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.48 per share. This reflects a positive earnings surprise of 10.42%. Look out for CPRX's next earnings release on May 08, 2024. For the next earning release, we expect the company to report earnings of $0.34 per share, reflecting a year-over-year increase of 30.77%.
Earnings History
Price & Consensus
Zacks News for CPRX
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
CPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services